Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases
Open Access
- 31 August 2007
- Vol. 110 (6), 1345-1350
- https://doi.org/10.1002/cncr.22906
Abstract
BACKGROUND. Whole‐brain radiotherapy (WBRT) to 30 grays (Gy) in 10 fractions is the standard treatment in patients with multiple brain metastases in the majority of treatment centers worldwide. The current study investigated the potential benefit of dose escalation beyond 30 Gy. METHODS. Data regarding 416 patients who were treated with WBRT for multiple brain metastases were evaluated retrospectively. Survival and freedom from recurrent brain metastasis (local control) of 257 patients who were treated with 10 fractions of 3 Gy each for 2 weeks were compared with those of 159 patients treated with 45 Gy in 15 fractions for 3 weeks or 40 Gy in 20 fractions for 4 weeks. Eight additional potential prognostic factors were investigated including age, gender, Karnofsky performance score (KPS), tumor type, interval between tumor diagnosis and RT, number of metastases, extracranial metastases, and Recursive Partitioning Analysis (RPA) class. RESULTS. On multivariate analysis, improved survival was found to be associated with lower RPA class (P < .001), age P = .026), KPS ≥70 (P < .001), and absence of extracranial metastases (P = .003). A trend was observed for number of metastases (2–3 vs ≥4; P = .07). Improved local control was associated with a KPS ≥70 (P < .001) and breast cancer (P < .001). A trend was observed for number of metastases (P = .059). The RT schedule did not appear to have any significant impact on survival (P = .86) or local control (P = .61). The subgroup analyses, performed for each of the 3 RPA classes, did not demonstrate a significantly better outcome with dose escalation. CONCLUSIONS. Dose escalation beyond 30 Gy in 10 fractions does not appear to improve survival or local control in patients with multiple brain metastases but does increase the treatment time and cost of therapy. Cancer 2007. © 2007 American Cancer Society.Keywords
This publication has 19 references indexed in Scilit:
- Radiosurgery for Single and Multiple Brain MetastasesPublished by Wiley ,2004
- Single- Versus Multiple-Fraction Radiotherapy in Patients With Painful Bone Metastases: Cost-Utility Analysis Based on a Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- Essai de phase III randomisé comparant la fotémustine seule ou associée à une irradiation encéphalique dans les métastases cérébrales de mélanome†Cancer/Radiothérapie, 2003
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology*Biology*Physics, 1997
- A randomized phase iii protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)International Journal of Radiation Oncology*Biology*Physics, 1991
- Radiation‐induced dementia in patients cured of brain metastasesNeurology, 1989
- Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brainJournal of Neuro-Oncology, 1984
- Intracerebral metastases in solid-tumor patients: Natural history and results of treatmentCancer, 1981
- The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958